State Attorneys General Launch Notification Program to Users of Antidepressant Drug Remeron
PIERRE, S.D. – Thousands of consumers from all 50 states may be entitled to a cash recovery based on their out-of-pocket expenses from purchasing the prescription antidepressant drug "Remeron" and its generic equivalent, "Mirtazapine," between June 15, 2001, and January 25, 2005.
The states’ lawsuit alleged that Organon unlawfully extended its monopoly by improperly listing a new “combination therapy” patent with the U.S. Food and Drug Administration. In addition, the complaint alleged that Organon delayed listing the patent with the DFA in another effort to delay the availability of low-cost generic substitutes. This resulted in higher prices to those who paid for the drug.
Consumers may call toll-free at 1-866-401-6807 or visit the settlement website at www.RemeronSettlement.com for information and claim forms. The address is: Remeron Antitrust Settlement, c/o Complete Claim Solutions, Inc., P.O. Box 24769, West Palm Beach, Florida 33416.
The filing deadline by mail or internet is June, 13, 2005.